WT1 and breast carcinoma: In addition, decreased levels of WT1 gene expression correlated with reduced cell proliferation in both melanoma and breast cancer cells [57, 58]. WT1 has also been linked with malignant transformation in breast cancer, and its overexpression associated with reduced susceptibility to drug treatment.